Latest Kidney Cancer News

Transcriptomic characterization and innovative molecular classification of clear cell renal cell carcinoma in the Chinese population

Prognostic role of smoking in metastatic renal cell carcinoma in real-world data from the Turkish Oncology Group Kidney Cancer Consortium (TKCC) – Scientific Reports

Thermal Ablation vs Surgery for Stage T1a RCC Offers Similar Cancer-Specific Survival – Oncology Nurse Advisor
Kidney Cancer News elsewhere on the Web

... (ccRCC) rather than non-ccRCC. The 5-year cancer-specific survival rate was 9.8% in patients with non-ccRCC and 20.7% in patients with ccRCC (P <.0001) ...

Partial nephrectomy showed similar overall and cancer-specific survival rates to radiofrequency ablation in patients with cT1a RCC.

Clear cell renal cell carcinoma (ccRCC) and ischemic stroke are critical global health challenges with a notable association. This study explores the correlation between tumor-related factors and ischemic stroke risk, aiming to construct a predictive nomogram model for ischemic stroke in ccRCC ...

... renal cell carcinoma model. Y. Kususda,; H. Miyake,; M. E. Gleave & … M. Fujisawa. Show authors. British Journal of Cancer (2024)Cite this ...

NDI-101150 monotherapy demonstrated antitumor activity and was well tolerated among patients with heavily pretreated renal cell carcinoma.

TFE3-rearranged Renal Cell Carcinoma (TFE3-RCC) is an aggressive subtype of RCC characterized by Xp11.2 rearrangement, leading to TFE3 fusion proteins with oncogenic potential. Despite advances in understanding its molecular biology, effective therapies for advanced cases remain elusive. This ...

During a Case-Based Roundtable® event, Daniel J. George, MD and participants discussed combination regimens for intermediate and poor-risk renal cell carcinoma.

ALLO-316, a CD70-directed CAR T-cell therapy, demonstrated preliminary efficacy and safety in CD70-positive ccRCC.

PD-L1 expression was found to predict better outcomes with Opdivo and Yervoy in patients with ccRCC, while high KIM-1 levels were linked to worse outcomes.

Renal and ovarian clear cell carcinoma (CCC) are both characterized by a clear cytoplasm and exhibit similar genomic alterations and clinical characteristics. We hypothesized that both CCCs may share clinical biomarker. Tissue factor pathway inhibitor 2 (TFPI2), a serine protease inhibitor, ...
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.





